CDXC - ChromaDex shares jump 9% on FDA designations for NRC
2024-06-07 09:51:21 ET
More on BioCardia, ChromaDex, etc.
- Charles River Laboratories: Fair Valuation Against Fundamentals
- BioCardia, Inc. (BCDA) Q1 2024 Earnings Call Transcript
- Collegium Pharmaceutical: Some Positives From Its Quarterly 'Miss'
- BioCardia intends to effect reverse stock split
- Collegium announces $35 million accelerated share repurchase program